Revealed, concealed, congealed, curdled: A reply to Pomichalek, Lamb, and Denner.

Replies to M. Pomichalek's (see record 1992-19269-001), S. Lamb's (see record 1992-19263-001), and B. Denner's (see record 1992-19257-001) remarks on P. Cushman's comments (see record 1991-17982-001) on D. Stern's (1985) study. Cushman defends constructionist research by maintaining that it can acknowledge and interpret ideology and thereby the moral framework in which the study is embedded. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Modernity, postmodernity, and psychology.

Responds to the S. Greer (see record 2001-00625-016), J. D. Raskin (see record 2001-00625-017), and M. Glassman (see record 2001-00625-018) comments on the J. Martin and J. Sugarman (see record 2000-08148-003) discussion on finding the middle ground between modern and postmodern approaches to psychology. All of the critiques are responded to in turn. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Happiness, flow, and economic equality.

Replies to comments by D. Belle et al (see record 2000-02781-018), S. Reiss (see record 2000-02781-019), T. B. Smith (see record 2000-02781-020), and J. R. Sink (see record 2000-02781-021) on the article by M. Csikszentmihalyi (see record 1999-11644-003) on materialism and the flow experience as an explanation of happiness. Csikszentmihalyi addresses the concerns of each author. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Heteroaryl analogues of AMPA. 2. Synthesis, absolute stereochemistry, photochemistry, and structure-activity relationships

We have previously shown that (S)-2-amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid [(S)-APPA, 2] is a weak agonist at (RS)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptors, specifically activated by (S)-AMPA (1), whereas (S)-2-amino-3-[3-hydroxy-5-(2-pyridyl)-4-isoxazolyl]propionic acid [(S)-2-Py-AMPA, 5] and (RS)-2-amino-3-[3-hydroxy-5-(2-thiazolyl)-4-isoxazolyl]propionic acid (4) are potent AMPA agonists. On the other hand, (R)-APPA (3) and (R)-2-Py-AMPA (6) have been shown to be weak AMPA antagonists. We now report the synthesis of 2-Py-AMPA (7a) and the isomeric compounds 3-Py-AMPA (7b) and 4-Py-AMPA (7c) as well as the 7a analogues, (RS)-2-amino-3-[3-hydroxy-5-(6-methyl-2-pyridyl)-4-isoxazolyl]p ropion ic acid (7d) and (RS)-2-amino-3-[3-hydroxy-5-(2-quinolinyl)-4-isoxazolyl]propionic acid (7e). Furthermore, (RS)-2-amino-3-[3-hydroxy-5-(2-furyl)-4-isoxazolyl]propionic acid (2-Fu-AMPA, 7f) and its 5-bromo-2-furyl derivative (7g) were synthesized, and (S)-2-Fu-AMPA (8) and (R)-2-Fu-AMPA (9) were prepared by semipreparative chiral HPLC resolution of 7f. HPLC analyses and circular dichroism spectroscopy indicated the absolute stereochemistry of 8 and 9 to be S and R, respectively. This was confirmed by an X-ray crystallographic analysis of 9.HCl. In receptor binding (IC50 values) and rat cortical wedge electrophysiological (EC50 values) studies, 7c (IC50 = 5.5 +/- 0.6 microM; EC50 = 96 +/- 5 microM) was shown to be markedly weaker than 7a (IC50 = 0.57 +/- 0.16 microM; EC50 = 7.4 +/- 0.2 microM) as an AMPA agonist, whereas 7b,d,e were inactive. The very potent AMPA agonist effect of 7f (IC50 = 0.15 +/- 0.03 microM; EC50 = 1.7 +/- 0. 2 microM) was shown to reside exclusively in 8 (IC50 = 0.11 +/- 0.01 microM; EC50 = 0.71 +/- 0.11 microM), whereas 9 did not interact significantly with AMPA receptors, either as an agonist or as an antagonist. 8 was shown to be photochemically active and is a potential photoaffinity label for the recognition site of the AMPA receptors. Compound 7g turned out to be a very weak AMPA receptor agonist (IC50 = 12 +/- 0.7 microM; EC50 = 160 +/- 15 microM). None of these new compounds showed detectable effects at N-methyl-d-aspartic acid (NMDA) or kainic acid receptors in vitro. The present studies have emphasized that the presence of a heteroatom in the 2-position of the heteroaryl 5-substituent greatly facilitates AMPA receptor agonist activity.     

Short-term effects of norethisterone oenanthate and medroxyprogesterone acetate on glucose, insulin, growth hormone, and lipids

The synthesis of (+/-)-1-ethylenedioxy-trans-2-(beta-R,S-hydroxypropyl)-3-(beta-acetoxyethyl)cyclopentane (IV), starting from (+/-)-1-ethylenedioxy-trans-2-propargyl-3-(beta-hydroxyethyl)cyclopentane (I) by indirect hydration with mercuric acetate and hydrogen sulphide, is reported.     

Effects of calcium antagonist, 6-(N, N-diethylamino) hexyl-3, 4, 5-trimethoxybenzoate, on digitalis-induced arrhythmias and cardiac contractions

6-(N, N-Diethylamino) hexyl-3, 4, 5-trimethylbenzoate (TMB-6) and lidocaine were equipotent (1 mg/kg) in the conversion of ectopic rhythms to normal rhythms in digoxin-toxic dogs. However, TMB-6 had fewer side effects on heart rates and dp/dt than lidocaine. TMB-6 inhibited the contractile force of electrically stimulated dog and guinea-pig atria and ventricles at concentrations ranging from 2.5 X 10(-5) to 1.7 X 10(-4) M. Elevation of extracellular Ca++ concentrations from 2.7 to 5.4 mM produced a significant increase in the ID50 of TMB-6 in atria (from 2.5 X 10(-5) to 5.0 X 10(-5) M in dogs and from 7.2 X 10(-5) to 1.0 X 10(-4) M in guinea pigs). TMB-6 (7.3 X 10(-5) to 2.4 X 10(-4) M) depressed the amplitude of Ca++-dependent action potentials in depolarized dog cardiac Purkinje fibers. These results are discussed with regard to the antagonism of TMB-6 on Ca++ availability in the myocardium which leads to the conversion of cardiac arrhythmias.     

Drugs, recipes, babies, bathwater, and psychotherapy process-outcome relations.

In their critiques of W. B. Stiles and D. A. Shapiro's (see record 1995-10433-001) discussion of the process-outcome correlation problem, G. Silberschatz (see record 1995-10428-001) and L. Sechrest (see record 1995-10426-001) suggested that the problem is not fundamental but merely technical. Silberschatz suggested that more complex measures would solve the problem; Sechrest suggested that more complex analyses would solve the problem. Following Sechrest's multivariate suggestions, however, produced no better result. Contrary to Silberschatz's and Sechrest's suggestions, the problem is not in the measures or the analyses but in the interpretation of the results (null results as well as positive results), particularly in a failure to incorporate fully the phenomenon of responsiveness into an understanding of process–outcome relations. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Comparisons among Tuli-, Brahman-, and Angus-sired heifers: intake, digesta kinetics, and grazing behavior

As part of an evaluation of Tuli crossbred cattle, forage intake, digesta kinetics, and grazing behavior were estimated in two Texas environments. In humid east Texas, Tuli x Brahman heifers were compared with purebred Angus and Brahman and Angus x Brahman heifers. Fecal output, forage intake, compartmental mass, and compartmental residence time did not differ among breeds. Angus and Brahman heifers had different (P < . 02) gastrointestinal residence times (51.1+/-1.56 vs 43.1+/-1.56 h, respectively), but values for the purebreds did not differ from those for Tuli x Brahman or Angus x Brahman heifers. Angus heifers had shorter (P < .05) 24-h grazing times (398+/-15.4 min/d) and fewer (P < .05) grazing periods (7+/-.4) than Tuli x Brahman (552+/-16.8 min/d and 10+/-.4), Angus x Brahman (507+/-18.4 min/d and 9+/-.5), and Brahman (560-/+ 16.8 min/d and 9+/-.4, respectively) heifers. In semiarid southwest Texas, Tuli x Angus heifers were compared with purebred Angus and Brahman and Brahman x Angus heifers. Fecal output and forage intake were similar in Tuli x Angus and Brahman x Angus heifers (14.2+/-.69 and 14.9+/-.91 g fecal DM/ [d.kg BW] and 24.5+/-1.33 and 25.6+/-1.75 g/d of forage DMI, respectively) but higher (P < .05) than those of purebred Brahman heifers (12.2+/-.64 and 20.3+/-1.23 g/[d.kg BW] of fecal DM and forage DMI, respectively). Grazing times did not differ among breeds. We conclude that Tuli-sired heifers are likely to be as productive as Brahman crossbred heifers in Texas, based on the similarities in intake, digesta dynamics, and grazing behavior.     

Bishop, Eysenck, Block, and psychoticism.

J. Block (see record 1978-28560-001) questioned evidence for the validity of the Eysenck Psychoticism (P) scale based on the psychophysiological findings of G. S. Claridge and H. J. Chappa (see record 1974-02520-001) that Ss high in psychoticism showed an unusual and counterintuitive relationship between 2-flash threshold and skin conductance. The present authors argue that Block's criticism that the result may be ephemeral is incorrect for 3 reasons. First, the cut-off point used to define the low skin conductance range over which the relationship was most evident was not as arbitrary as Block suggests. Second, replication data demonstrated the same result. And third, the unusual psychophysiology found in high P Ss has also been observed in normal Ss under LSD-25 and in acute schizophrenics. However, the present authors also point out that all their work on psychoticism was based on an earlier version of the Eysenck Personality Inventory (the Psychoticism-Extraversion-Neuroticism Inventory), whose items may have more face validity than the published version. Finally, D. V. M. Bishop's (see record 1978-30744-001) interpretation of the present authors' dimensional concept of psychoticism is corrected. (15 ref) (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Reaction of myeloperoxidase compound I with chloride, bromide, iodide, and thiocyanate

Myeloperoxidase plays a fundamental role in oxidant production by neutrophils. The enzyme uses hydrogen peroxide to oxidize chloride (Cl-), bromide (Br-), iodide (I-), and the pseudohalide thiocyanate (SCN-) to their respective hypohalous acids. This study for the first time presents transient kinetic measurements of the oxidation of these halides and thiocyanate by the myeloperoxidase intermediate compound I, using the sequential mixing stopped-flow technique. At pH 7 and 15 degrees C, the two-electron reduction of compound I to the native enzyme by Cl- has a second-order rate constant of (2.5 +/- 0.3) x 10(4) M(-1) s(-1), whereas reduction of compound I by SCN- has a second-order rate constant of (9.6 +/- 0.5) x 10(6) M(-1) s(-1). Iodide [(7.2 +/- 0.7) x 10(6) M(-1) s(-1)] is shown to be a better electron donor for compound I than Br- [(1.1 +/- 0.1) x 10(6) M(-1) s(-1)]. The pH dependence studies suggest that compound I reduction by (pseudo-)halides is controlled by a residue with a pKa of about 4.6. The protonation of this group is necessary for optimum (pseudo-)halide anion oxidation. These transient kinetic results are underlined by steady-state spectral and kinetic investigations. SCN- is shown to be most effective in shifting the system myeloperoxidase/hydrogen peroxide from the peroxidatic cycle to the halogenation cycle, whereas iodide is shown to be more effective than bromide which in turn is much more effective than chloride. Decreasing pH increases the rate of this transition. Our results show that thiocyanate is an important substrate of myeloperoxidase in most environments and that hypothiocyanate is likely to contribute to leukocyte antimicrobial activity.     

Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators

OBJECTIVES:The present investigation was designed to determine the best endogenous plasma marker of early congestive heart failure (CHF). METHODS: Forty volunteers with mild CHF (New York Heart Association Class I, n = 12), moderate (Class II, n = 8), or severe (Class III and Class IV, each = n of 5) and 10 age-matched healthy individuals had the simultaneous evaluation of their respective plasma samples by the following radioimmunoassays: atrial natriuretic peptide, ANP; three N-terminal ANP prohormone assays, i.e., proANPs 1-30, 31-67, and 79-98 with the numbers referring to their amino acid (a.a.) sequences in their 126 a.a. prohormone; brain (BNP) and C-natriuretic peptides; N-terminal BNP prohormone; adrenomedullin; neuropeptide Y and endothelin. RESULTS: ProANPs 31-67, 1-30 and 79-98 had 100% (P = 0.01), 83% (P = 0.09) and 50% (P = 0.74) sensitivity in differentiating Class I CHF subjects from healthy subjects. The ANP, BNP, NT-proBNP, CNP, adrenomedullin, neuropeptide Y, and endothelin assays could not differentiate mild CHF subjects from healthy individuals. Logistic regression analysis revealed that only proANP 31-67 significantly (P = 0.0001) discriminated between early CHF (5226 +/- 377 pg/ml) and healthy individuals (1595 +/- 157 pg/ml). The positive and negative predicative values of proANP 31-67 were excellent (100% for each). The peptides measured in these assays were found to be independent markers of CHF with respect to left ventricular ejection fraction. CONCLUSIONS: ProANPs 31-67 is the most sensitive marker in discriminating NYHA Class I CHF subjects from healthy individuals. The ANP, BNP, NT-proBNP, CNP, adrenomedullin, neuropeptide Y and endothelin radioimmunoassays cannot discern mild CHF. These peptides are independent of left ventricular ejection fraction.     

Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes

Of all skeletal muscles examined in the rat, the spinotrapezius (S) and diaphragm (D) have the closest fiber-type composition. However, their oxidative capacities differ by two- to threefold. We have developed an intravital microscopy preparation to study diaphragm microcirculation in vivo. Using this preparation and the standard spinotrapezius model first described by S. D. Gray (1973, Microvasc. Res. 5, 395-400), we tested the hypothesis that pronounced microcirculatory differences would exist between these two muscles as a function of their disparate oxidative capacities. The lineal density of all capillaries in the spinotrapezius was 33.6 +/- 1.5 compared to 65.1 +/- 3.3 capillaries/mm in the diaphragm (P < 0.001). In the diaphragm compared with the spinotrapezius muscle, a significantly (P < 0.05) greater proportion of capillary countercurrent flow (D, 29 +/- 6% vs 8 +/- 6%) existed. Within both muscles, there was a similar proportion of capillaries supporting red blood cell (RBC) flow (S, 89 +/- 7% vs D, 92 +/- 2%). However, the diaphragm supported significantly (P < 0.001) greater intracapillary RBC velocities (D, 302 +/- 11 vs S, 226 +/- 9 micron/s) and fluxes (D, 33.4 +/- 1.1 vs S, 19.2 +/- 2.1 cells/s) compared with the spinotrapezius. Capillary "tube" hematocrit was greater (P = 0.01) in the diaphragm (0.32 +/- 0.02) than in the spinotrapezius (0.22 +/- 0.03) muscle. These data demonstrate that microcirculatory flow characteristics in resting muscle can be regulated independent of muscle fiber-type composition and may be related to muscle oxidative capacity.     

Replies to Danet, Lubin, and Hurvitz.

Responds to comments on Shostrom's (see record 1990-55846-001) work on televised group psychotherapy by B. N. Danet (see record 1990-55869-001); B. Lubin (see record 1990-55870-001); and N. Hurvitz (see record 1990-55871-001). Topics discussed include (1) the equivalence of focused audiovisual feedback vs televised "open' group therapy, (2) the .50 level of "significance' reported by Shostrom, and (3) the preference for educational vs commercial TV presentation. (0 ref) (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Plasma levels of parathyroid hormone, vitamin D, calcitonin, and calcium in association with endurance exercise

Nine male marathon runners were investigated during habitual training (week 0), after 3 weeks of training break (week 3), and after 2 weeks (week 5) and 4 weeks (week 7) of retraining. Maximal oxygen uptake, body fat (BF), and plasma levels of 25(OH)D3, 1,25(OH)2D3, parathyroid hormone (PTH), calcitonin (CT), albumin, and albumin-corrected calcium were determined throughout weeks 0-7. The maximal oxygen uptake decreased after training break and increased during retraining (P = 0.002). BF did not change significantly. Plasma 1,25(OH)2D3 was elevated after training break and decreased after 2 and 4 weeks of retraining [week 0: 44.0 +/- 3.7 (SEM) pg x 1(-1); week 3: 52.4 +/- 6.0 pg x 1(-1); week 5: 42.0 +/- 2.8 pg x 1(-1); week 7: 36.9 +/- 2.3 pg x 1(-1); P = 0.03]. Plasma 25(OH)D3 did not change significantly. Plasma PTH increased throughout the training break and retraining (week 0: 1.36 +/- 0.25 pmol x 1(-1); week 3: 2.02 +/- 0.43 pmol x 1(-1); week 5: 2.23 +/- 0.60 pmol x 1(-1); week 7: 2.63 +/- 0.34 pmol x 1(-1); P = 0.03). Albumin-corrected calcium values were transiently decreased during retraining (week 3: 2.77 +/- 0.08 mM; week 5: 2.47 +/- 0.05 mM; week 7: 2.66 +/- 0.07 mM; P = 0.01). Plasma CT did not change during training break, but was transiently decreased during retraining (week 0: 9.97 +/- 0.39 pmol x 1(-1); week 3: 9.91 +/- 0.37 pmol x 1(-1); week 5: 8.19 +/- 0.50 pmol x 1(-1); week 7: 9.02 +/- 0.45 pmol x 1(-1); P = 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)     

Effects of a K+ATP channel opener, lemakalim, on systemic, coronary and regional vascular dynamics in conscious dogs: comparison with nifedipine, adenosine, nitroglycerin and acetylcholine

The systemic, coronary and regional vascular responses to the K+ATP channel opener lemakalim were compared to other potent vasodilators (i.e., nifedipine, adenosine, nitroglycerin and acetylcholine). Experiments were performed in 12 conscious dogs 2 to 4 weeks after implantation of aortic catheters and flow probes on the ascending aorta, left circumflex coronary, celiac, mesenteric, renal and iliac arteries, and solid-state miniature pressure gauges in the left ventricular cavity. Dose-response curves induced by bolus injection (i.v.) were examined. For doses that reduced total peripheral resistance by 22%, lemakalim reduced celiac (-28 +/- 2%), mesenteric (-24 +/- 3%), renal (-17 +/- 3%) and iliac (-18 +/- 3%) vascular resistances (i.e., by amounts similar to those observed with the other vasodilators, except for adenosine, which increased renal resistance). At these doses, lemakalim induced a greater decrease (-52 +/- 3%) (P < .05) in coronary resistance, as compared with nifedipine (-35 +/- 3%), adenosine (-38 +/- 3%), nitroglycerin (-25 +/- 2%) and acetylcholine (-32 +/- 3%). However, when near maximal vasodilation was elicited, adenosine elicited the greatest (P < .05) decrease in coronary resistance (-81 +/- 1%), as compared with lemakalim (-74 +/- 2%), nifedipine (-67 +/- 2%), nitroglycerin (-63 +/- 2%) and acetylcholine (-72 +/- 1%). Both the time to maximal increases in regional blood flow and the time for recovery in all vascular beds were significantly prolonged for lemakalim compared with the other vasodilators. Thus, the K+ATP channel opener lemakalim dilates the coronary bed out of proportion to other vascular beds, is relatively more potent at lower doses than other vasodilators and exhibits a delayed and more prolonged action in all regional vascular beds.     

A new anthracycline antibiotic, IT-62-B, converts the morphology of ras-transformed cells back to normal: taxonomy, fermentation, isolation, structure elucidation and biological characterization

beta-(2-Hydroxyethoxy)-5 alpha-cholest-8(14)-en-15-one, a synthetic inhibitor of cholesterol biosynthesis, was shown to exhibit a high affinity to oxysterol binding protein. This was proved by ultracentrifugation of the protein fraction from rabbit liver in the presence of the 3H-labeled inhibitor, 3 beta-(2-hydroxy-2-[3H]ethoxy)-5 alpha-cholest-8(14)-en-15-one, or by the substitution of the [3H]-25-hydroxycholesterol in its complex with the oxysterol binding protein. In human hepatoma Hep G2 cells, the inhibitor decreased activity of 3-hydroxy-3-methylglutaryl CoA reductase [ID50 (2.7 +/- 0.7) x 10(-5) M] and was transformed into 3 beta-[2-(9-Z-octadecenoyloxy)ethoxy]-5 alpha-cholest-8(14)-en-15-one.     

Cardiovascular and metabolic costs of forward, backward, and lateral motion

PURPOSE: The purpose of this study was to compare the metabolic and cardiovascular responses of movement in forward (FM), backward (BM), and lateral (LM) directions. METHODS: Thirteen athletes with the following characteristics (mean +/- SD) were evaluated: age 21+/-3 yr, height 172.0+/-9.0 cm, weight 62.92+/-9.05 kg, and VO2max 54.13+/-7.42 mL x kg(-1) x min(-1). Subjects were evaluated at 80.45 and 134.08 m x min(-1). A repeated measures ANOVA was used for statistical analysis (P < 0.05). RESULTS: At 80.45 m x min(-1), the following respective VO2 mL x kg(-1) x min(-1) and heart rate (HR) beats x min(-1) responses were: FM = 12.42+/-2.29, 113+/-10; BM = 15.95+/-2.45, 132+/-16; and LM = 22.10+/-4.76, 140+/-15. Both VO2 and HR were significantly different between conditions: LM > BM > FM. At 134.08 m x min(-1), the following respective VO2 and HR responses were: FM = 27.15+/-2.51, 146+/-7; BM = 31.33+/-5.77, 168+/-11; and LM = 32.58+/-5.74, 169+/-10. At 134.08 m x min(-1) neither HR or VO2 were significantly different between LM or BM (LM, BM, > FM). Stride length and stride frequency were also significantly different between conditions. These results indicate the variation in the energy cost of FM, BM, and LM.     

A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC and follistatin during pregnancy

Maternal serum concentrations of inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC-related inhibin forms, total follistatin, steroids and gonadotrophins were measured longitudinally in six normal singleton pregnancies. Maternal venous blood was collected randomly during a spontaneous follicular phase prior to donor insemination, at 5, 7, 9, 11, 16, 20, 24, 28, 32 and 36 weeks after the first missed menses and in the early puerperium. Steroid and gonadotrophin profiles conformed to previous reports. While at week 5 of gestation inhibin-A, activin-A and follistatin concentrations were similar to those at the follicular phase, all three increased progressively (P < 0.001) to maximal concentrations in week 36: approximately 48-fold (3740 +/- 1349 ng inhibin-A/ml), approximately 22-fold (6109 +/- 1443 ng activin-A/ml) and approximately 10-fold (3563 +/- 418 ng follistatin/ml) higher. Pro-alphaC concentrations reached a maximum in weeks 5 (approximately 5-fold, P < 0.001) and 36 (1027 +/- 174 pg/ml, P < 0.01). Inhibin-B (71 +/- 23 pg/ml prior to pregnancy) was undetectable (<12 pg/ml) between week 5-16 of gestation but increased slightly in the third trimester (26 +/- 7 pg/ml in week 36). Activin-AB was undetectable throughout pregnancy. Post-partum concentrations of inhibin-A (41 +/- 12 ng/ml), inhibin-B (<12 pg/ml), activin-A (950 +/- 149 pg/ml), pro-alphaC (128 +/- 22 pg/ml) and follistatin (990 +/- 79 ng/ml) were substantially lower than at week 36 of gestation. The activin-A:follistatin ratio increased from 0.5 in week 5 to 1.8 in week 36, suggesting that more free activin-A is available in the maternal circulation during late pregnancy.     

Interactionism, flexibility, and inferences about the past.

Addresses key issues raised by the nine preceding commentators (see records 1999-05337-005, 1999-05337-006, 1999-05337-007, 1999-05337-008, 1999-05337-009, 1999-05337-010, 1999-05337-011, 1999-05337-012, and 1999-05337-013) on the present authors' article "Adaptations, Exaptations, and Spandrels" (see record 1998-01669-001). (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Studies on the activity, properties and isoenzymes of acid phosphatase in the erythrocytes of swine, horse, dog, cat, duck and chicken

Acid phosphatase of erythrocytes of several species was investigated, with three isozymes having been recorded from swine (three types), three (two types) from horse, four (one type) from dog, two (two types) from cat, two (three types) from duck, and two (one type) from fowl. The Michaelis constant of the enzyme varied between 3.5 and 5 X 10(-4) M for the species involved. The species, however, differed slightly for the optimum pH of the enzyme. The average enzymatic activities were (5.68 +/- 0.42 for dog, 4.46 +/- 1.0 for horse, 3.8 +/- 0.24 for swine, 3.72 for cat, 2.5 +/- 0.62 for duck, and 1.9 +/- 0.8 for fowl. All values are units per gram haemoglobin. Even relatively low concentrations (0.2 or 1 mM) of copper, mercury, and cadmium ions were found to be strong inhibitors of the acid erythrocyte phosphatase.